Novartis Pharmaceuticals Corp. (NPC) disputes the allegations made by the US Attorney's Office or USAO for the Southern District of New York SDNY in two complaints filed this week and will defend itself in these litigations.
"We disagree with the way the government is characterizing our conduct in both of these matters and we stand behind our Compliance program," said Andre Wyss, President, Novartis Pharmaceuticals Corporation and President, Novartis Corporation.
The company said that the first suit pertains to a previously disclosed investigation into discounts and rebates to specialty pharmacies for Myfortic®.
NPC believes this suit is a significant expansion of the Anti-Kickback Statute that is inconsistent with law and policy in this area, and threatens to undermine pharmaceutical company discounting practices that benefit both consumers and payers, including the Government.
Click here to receive FREE breaking news email alerts for Novartis AG and others in your portfolio
by RTT Staff Writer
For comments and feedback: email@example.com